Coates As

Interferon-alpha 2a does not improve response or survival when combined with dacarbazine in metastatic malignant melanoma: results of a multi-institutional Australian randomized trial.

Thomson Db, Michael Adena, McLeod Gr et al. · PubMed · 1993 · 118 citations

Pharmacy, Oncology, Pharmacotherapy +17

Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial

Giuseppe Viale, MM Regan, Patrizia Dell’Orto et al. · Annals of Oncology · 2011 · 104 citations · Full text

Medicine, Oncology, Pharmacology +14

Elective lymph node dissection in patients with primary melanoma of the trunk and limbs treated at the Sydney Melanoma unit from 1960 to 1991.

Coates As, Ingvar Ci, Karin Petersen-Schaefer et al. · PubMed · 1995 · 58 citations

Medicine, Oncology, Surgery +16

The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up

Marco Colleoni, Zijie Sun, Giovanni Martinelli et al. · Annals of Oncology · 2009 · 19 citations · Full text

Medicine, Endocrinology, Oncology +13